• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与骨髓增生异常综合征相关的继发性肺泡蛋白沉积症的临床特征:两例报告

Clinical features of secondary pulmonary alveolar proteinosis associated with myelodysplastic syndrome: Two case reports.

作者信息

Liu Yin, Chen Lu Lu, Qiu Yu Ying, Xiao Yong Long, Cai Hou Rong

机构信息

Department of Respiratory, Drum Tower Hospital, Nanjing University Medical School, Nanjing, Jiangsu, China.

出版信息

Medicine (Baltimore). 2017 Nov;96(44):e8481. doi: 10.1097/MD.0000000000008481.

DOI:10.1097/MD.0000000000008481
PMID:29095306
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5682825/
Abstract

RATIONALE

Pulmonary alveolar proteinosis (PAP) is a rare lung disorder characterized by the abnormal accumulation of alveolar surfactant protein in alveolar spaces. Secondary PAP can result from myelodysplastic syndrome (MDS).

PATIENT CONCERNS

But most reports described a single case; here we reported 2 cases of PAP secondary to MDS. One case developed secondary PAP at the same time as MDS, and the other developed during the course of MDS.

DIAGNOSES

The diagnosis of PAP was made by bronchoalveolar lavage and based on the identification of periodic acid-Schiff-positive proteinaceous material. Chest high resolution CT (HRCT) scans showed variable distribution of ground glass opacities, but crazy-paving appearance was not seen in our 2 cases.

INTERVENTIONS

Because the patients' general conditions were poor, whole lung lavage was not used in the 2 cases.

OUTCOMES

And the 2 cases' prognoses were poor.

LESSONS

In conclusion, pulmonary physicians should suspect the possibility of secondary PAP when they encounter unexplained pulmonary infiltrates with some hematologic or infectious disease that shows diffuse bilateral GGO on an HRCT scan.

摘要

理论依据

肺泡蛋白沉积症(PAP)是一种罕见的肺部疾病,其特征是肺泡表面活性物质蛋白在肺泡腔内异常蓄积。继发性PAP可由骨髓增生异常综合征(MDS)引起。

患者情况

但大多数报告描述的是单个病例;在此我们报告2例继发于MDS的PAP。1例在诊断MDS的同时发生继发性PAP,另1例在MDS病程中发生。

诊断

PAP的诊断通过支气管肺泡灌洗并基于过碘酸雪夫染色阳性的含蛋白质物质的鉴定。胸部高分辨率CT(HRCT)扫描显示磨玻璃影分布多样,但我们的2例患者均未见铺路石征。

干预措施

由于患者一般情况较差,这2例患者未采用全肺灌洗。

结果

这2例患者预后较差。

经验教训

总之,肺科医生在遇到原因不明的肺部浸润且伴有某些血液系统疾病或感染性疾病,同时HRCT扫描显示双肺弥漫性磨玻璃影时,应怀疑继发性PAP的可能性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/940c/5682825/2902ab33c6eb/medi-96-e8481-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/940c/5682825/31db1f82b325/medi-96-e8481-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/940c/5682825/c93054479807/medi-96-e8481-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/940c/5682825/2902ab33c6eb/medi-96-e8481-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/940c/5682825/31db1f82b325/medi-96-e8481-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/940c/5682825/c93054479807/medi-96-e8481-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/940c/5682825/2902ab33c6eb/medi-96-e8481-g003.jpg

相似文献

1
Clinical features of secondary pulmonary alveolar proteinosis associated with myelodysplastic syndrome: Two case reports.与骨髓增生异常综合征相关的继发性肺泡蛋白沉积症的临床特征:两例报告
Medicine (Baltimore). 2017 Nov;96(44):e8481. doi: 10.1097/MD.0000000000008481.
2
Clinical features of three cases with pulmonary alveolar proteinosis secondary to myelodysplastic syndrome developed during the course of Behçet's disease.3例白塞病病程中发生骨髓增生异常综合征继发肺泡蛋白沉积症患者的临床特征。
Respir Investig. 2014 Jan;52(1):75-9. doi: 10.1016/j.resinv.2013.05.005. Epub 2013 Jul 3.
3
[Secondary pulmonary alveolar proteinosis associated with myelodysplastic syndrome].[与骨髓增生异常综合征相关的继发性肺泡蛋白沉积症]
Nihon Kokyuki Gakkai Zasshi. 2002 Jul;40(7):599-604.
4
Case Report: The first reported case of pulmonary alveolar proteinosis with myasthenia gravis in a 27-year-old patient.病例报告:27 岁患者患肺泡蛋白沉积症合并重症肌无力,为首例报道。
F1000Res. 2023 Aug 21;11:1439. doi: 10.12688/f1000research.127299.2. eCollection 2022.
5
Pulmonary alveolar proteinosis as a terminal complication in myelodysplastic syndromes: a report of four cases detected on autopsy.肺泡蛋白沉积症作为骨髓增生异常综合征的终末期并发症:4例尸检病例报告
Leuk Res. 2002 Jun;26(6):591-5. doi: 10.1016/s0145-2126(01)00178-3.
6
Pulmonary alveolar proteinosis.肺泡蛋白沉积症。
Semin Respir Crit Care Med. 2012 Oct;33(5):498-508. doi: 10.1055/s-0032-1325160. Epub 2012 Sep 21.
7
Comparative study of high-resolution CT findings between autoimmune and secondary pulmonary alveolar proteinosis.自身免疫性与继发性肺泡蛋白沉积症高分辨率 CT 表现的对比研究。
Chest. 2009 Nov;136(5):1348-1355. doi: 10.1378/chest.09-0097.
8
Secondary pulmonary alveolar proteinosis: a single-center retrospective study (a case series and literature review).继发性肺泡蛋白沉积症:一项单中心回顾性研究(病例系列和文献复习)。
BMC Pulm Med. 2018 Jan 25;18(1):15. doi: 10.1186/s12890-018-0590-z.
9
Pulmonary alveolar proteinosis with myeloproliferative syndrome with myelodysplasia: bronchoalveolar lavage reduces white blood cell count.伴有骨髓增生异常的骨髓增殖综合征的肺泡蛋白沉积症:支气管肺泡灌洗可降低白细胞计数。
Am J Hematol. 2006 Aug;81(8):634-8. doi: 10.1002/ajh.20670.
10
Secondary Pulmonary Alveolar Proteinosis Following Treatment with Azacitidine for Myelodysplastic Syndrome.阿扎胞苷治疗骨髓增生异常综合征后发生的继发性肺泡蛋白沉积症
Intern Med. 2020 Apr 15;59(8):1081-1086. doi: 10.2169/internalmedicine.3770-19. Epub 2019 Dec 26.

引用本文的文献

1
Chronic myelomonocytic leukemia-associated pulmonary alveolar proteinosis: A case report and review of literature.慢性粒单核细胞白血病相关的肺泡蛋白沉积症:一例报告并文献复习
World J Clin Cases. 2021 Feb 16;9(5):1156-1167. doi: 10.12998/wjcc.v9.i5.1156.
2
Secondary Pulmonary Alveolar Proteinosis Following Treatment with Azacitidine for Myelodysplastic Syndrome.阿扎胞苷治疗骨髓增生异常综合征后发生的继发性肺泡蛋白沉积症
Intern Med. 2020 Apr 15;59(8):1081-1086. doi: 10.2169/internalmedicine.3770-19. Epub 2019 Dec 26.

本文引用的文献

1
A lymphocyte-mediated cause of secondary PAP.淋巴细胞介导的继发性 PAP 病因。
Blood. 2015 Jan 8;125(2):215-6. doi: 10.1182/blood-2014-11-610618.
2
A case of secondary pulmonary alveolar proteinosis, but prior to myelodysplastic syndrome.一例继发性肺泡蛋白沉积症,但早于骨髓增生异常综合征。
Respirol Case Rep. 2013 Dec;1(2):58-61. doi: 10.1002/rcr2.29. Epub 2013 Oct 31.
3
T-cell-restricted T-bet overexpression induces aberrant hematopoiesis of myeloid cells and impairs function of macrophages in the lung.T细胞限制性T-bet过表达诱导髓系细胞异常造血并损害肺巨噬细胞功能。
Blood. 2015 Jan 8;125(2):370-82. doi: 10.1182/blood-2014-05-575225. Epub 2014 Oct 27.
4
Secondary pulmonary alveolar proteinosis complicating myelodysplastic syndrome results in worsening of prognosis: a retrospective cohort study in Japan.继发于骨髓增生异常综合征的肺朗格汉斯细胞组织细胞增生症导致预后恶化:日本的一项回顾性队列研究。
BMC Pulm Med. 2014 Mar 5;14:37. doi: 10.1186/1471-2466-14-37.
5
Possible association of trisomy 8 with secondary pulmonary alveolar proteinosis in myelodysplastic syndrome.8号染色体三体与骨髓增生异常综合征继发性肺泡蛋白沉积症之间可能存在的关联。
Am J Respir Crit Care Med. 2011 Jul 15;184(2):279-80. doi: 10.1164/ajrccm.184.2.279a.
6
Pulmonary alveolar proteinosis as a terminal complication in a case of myelodysplastic syndrome with idic(20q-).肺肺泡蛋白质沉积症作为骨髓增生异常综合征伴idic(20q-)的终末期并发症。
Acta Haematol. 2010;123(1):55-8. doi: 10.1159/000262292. Epub 2009 Dec 2.
7
Comparative study of high-resolution CT findings between autoimmune and secondary pulmonary alveolar proteinosis.自身免疫性与继发性肺泡蛋白沉积症高分辨率 CT 表现的对比研究。
Chest. 2009 Nov;136(5):1348-1355. doi: 10.1378/chest.09-0097.
8
Successful allogeneic bone marrow transplantation for myelodysplastic syndrome complicated by severe pulmonary alveolar proteinosis.异基因骨髓移植治疗骨髓增生异常综合征合并严重肺泡蛋白沉积症。
Int J Hematol. 2009 Oct;90(3):407-412. doi: 10.1007/s12185-009-0404-4. Epub 2009 Aug 20.
9
Secondary pulmonary alveolar proteinosis: a confusing and potentially serious complication of hematologic malignancy.继发性肺泡蛋白沉积症:血液系统恶性肿瘤中一种令人困惑且可能严重的并发症。
J Thorac Imaging. 2009 May;24(2):115-8. doi: 10.1097/RTI.0b013e3181930ed6.
10
Secondary pulmonary alveolar proteinosis associated with myelodysplastic syndrome.与骨髓增生异常综合征相关的继发性肺泡蛋白沉积症。
Chin Med J (Engl). 2007 Jun 20;120(12):1114-6.